My watch list  

Diamyd Medical AB

Linnégatan 89 B
115 23 Stockholm

Company Portrait

Diamyd Medical is a life science company developing treatments for diabetes and its complications. The company’s furthest developed project is the GAD-based drug Diamyd® for autoimmune diabetes for which Phase III studies are planned. Diamyd® has demonstrated significant and positive results in Phase II clinical trials in Sweden.

Focus: Manufacturer

Industrial Sectors

  • Pharma
More about Diamyd Medical
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE